abstract |
Of mesenchymal stem cells that express interleukin-8 (IL-8) or GRO-α and are isolated from umbilical cord blood and / or mesenchymal stem cells grown from the mesenchymal stem cells (UCB-MSC) Provided is a gene therapy composition that transmits one of a therapeutic gene, a marker gene, or a mixture thereof to a cell that induces migration. The cell therapy composition includes UCB-MSC. By using UCB-MSC, a composition for treating a disease relating to cells expressing IL-8 or GRO-α in gene therapy, that is, a brain tumor is provided. Compositions or kits for diagnosing brain tumors, preventing brain tumors, treating brain tumors, or monitoring the course of treatment of brain tumors by using UCB-MSCs are provided. |